IBDHorizons June 24th Oklahoma Dialogue
Navigating UC Therapies Today
Moderated by Dr. Anita Afzali and Dr. Tauseef Ali
Based on emerging data, new publications, and the latest developments at the recent national and international IBD meetings, the program will focus on a practical approach to managing adults with IBD. Given the expansive therapeutic options, the discussion will follow a CD or UC case from diagnosis onwards with the goal of sharing experience between the moderators and attendees. Both moderators bring wide expertise as experts in the field of IBD. Discussions will be case-based regarding treatment pipeline, safety and durability of therapies, and positioning of therapies.
- Date: Thursday, June 24, 2021
- Time: 6:00 to 8:00 PM
- Location: Virtual IBDHorizons platform
- Attendees: 15-20 physician attendees
- Dinner: provider via local venues
- Non-CME accredited program
- Format: Main session with no breakout rooms, program not recorded
- Dr. Anita Afzali, Associate Professor of Medicine, Medical Director – OSU Inflammatory Bowel Disease Center, Columbus, OH
- Dr. Tauseef Ali – SSM Health St. Anthony Hospital, Oklahoma City, OK
If you are interested in having an IBDHorizons Dialogue locally with your practice, reach out to firstname.lastname@example.org
Key Account Manager – Texas/Oklahoma
Takeda Pharmaceuticals U.S.A, Inc.
- 6:00 - 6:30
- Introduce IBDHorizons, Introduce attendees, moderators. Time for virtual exhibits
- 6:30 - 8:00
- Present Three UC Cases
- Each followed by open discussion
Speakers:Anita Afzali, Tauseef Ali
- 8:00 - 8:30
- Closing remarks
Anita Afzali MD, MPH, Associate Professor of Clinical Medicine, Gastroenterologist, Medical Director of OSU IBD Center, Director of Operations for the Division of Gastroenterology, Hepatology and NutritionAnita AfzaliMD, MPH, Associate Professor of Clinical Medicine, Gastroenterologist, Medical Director of OSU IBD Center, Director of Operations for the Division of Gastroenterology, Hepatology and Nutrition
Dr. Anita Afzali is an Associate Professor of Clinical Medicine and a Gastroenterologist that specializes in Inflammatory Bowel Disease (IBD) at The Ohio State University Wexner Medical Center. She is the Director of Operations for the Division of Gastroenterology, Hepatology, and Nutrition, as well as the Medical Director of the OSU Inflammatory Bowel Disease Center. She holds the Abercrombie & Fitch Endowed Chair in Inflammatory Bowel Disease. She received her medical degree and then completed an Internal Medicine residency and Gastroenterology fellowship at the University of Washington in Seattle, WA. While in fellowship, Dr. Afzali worked in outcomes research and epidemiology, and also graduated with a Master’s in Public Health. Her sub-specialty training includes a one-year advanced IBD fellowship at the University of Washington, prior to becoming faculty. While practicing at the University of Washington – Harborview Medical Center, Dr. Afzali served as the Director of the IBD Program and Associate Medical Director of Gastroenterology Clinics. Her research interests include clinical outcomes and association of bowel and joint disease, the influence of the metabolic syndrome and impact of race/ethnicity in IBD, as well as pharmacoeconomics, pediatric-to-adult transition, and women of childbearing age with IBD. She is also extensively involved in IBD clinical trials for investigational therapies. She has extensive peer-reviewed publications, an invited lecturer on national and international programs, and serves on several international advisory boards and committees including Co-Chair of the Crohn’s & Colitis National Professional Education Committee and Member of the ACG Minority Affairs and Cultural Diversity Committee.
Tauseef AliMD, MPH, FACG, Consultant Gastroenterologist, Clinical Assistant Professor of Medicine
Dr. Tauseef Ali is a consultant gastroenterologist at SSM Health Saint Anthony Hospital. He is also a Clinical Assistant Professor of Medicine at the University of Oklahoma in the section of Digestive Disease and Nutrition and adjunct faculty at Oklahoma State University. He is the chief of the Gastroenterology Section at SSM Health Saint Anthony Hospital, Oklahoma, where he also serves as director of IBD Clinical and Research program. Dr. Ali graduated from King Edward Medical College, Pakistan (2001). He completed his internal medicine residency (2006) and Gastroenterology fellowship (2009) program from the University of Oklahoma Health Sciences Center. He was also selected as the CCFA visiting IBD fellow at the University of Chicago (2008).
His clinical interest includes Inflammatory Bowel Disease. He was the recipient of the AGA Bridges to Excellence Award to provide quality service to IBD patients. He is the author of Crohn’s and Colitis for Dummies book by Wiley Publishers. He is a fellow member of the American College of Gastroenterology (ACG) and has served on ACG International Relations, Training, Educational Affairs, Bylaws, membership and Public Relations Committees.
Dr. Ali is currently serving as the Chair of the American College of Gastroenterology Public Relations Committee. He has been the recipient of the ACG United States and World Gastroenterology Train the Trainers Program Travel Award. He has served as section editor for Inflammatory Bowel Disease in the ACG Self-Assessment Test subcommittee. His research interest is in sleep-related disorders in IBD patients. He is member of American College of Physicians, American Gastroenterological Association and Crohn’s and Colitis Foundation. He is an active member of the Govt. and Industry Affairs Committee and Diversity and Inclusion Taskforce of Crohn’s and Colitis Foundation. He is recognized as the community leader and moderator for the ACG and CCFA IBD Circle, an online physician discussion forum. He regularly tweets through is educational twitter accounts @ibdtweets and the founder and moderator of social media international ibd journal club (@ibdclub). Dr. Ali is currently serving as the American College of Gastroenterology Governor for Oklahoma Chapter.